Literature DB >> 20722764

The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.

Jeroen van Bergen1, Frits Koning.   

Abstract

The killer cell immunoglobulin-like receptor (KIR) locus comprises a variable and rapidly evolving set of genes encoding multiple inhibitory and activating receptors. The activating receptors recently evolved from the inhibitory receptors and both bind HLA class I and probably also class I-like structures induced by viral infection. Although generally considered natural killer (NK) cell receptors, KIR are also expressed by a large fraction of effector memory T cells, which slowly accumulate during human life. These effector memory cells are functionally similar to NK cells, as they are immediate effector cells that are cytotoxic and produce IFN-γ. However, different rules apply to NK and T cells with respect to KIR expression and function. For example, KIR tend to modulate signals driven by the T-cell receptor (TCR) rather than to act independently, and use different signal transduction pathways to modulate only a subset of effector functions. The most important difference may lie in the rules governing tolerance: while NK cells with activating KIR binding self-HLA are hyporesponsive, the same is unlikely to apply to T cells. We argue that the expression of activating KIR on virus-specific T cells carrying TCR that weakly cross-react with autoantigens can unleash the autoreactive potential of these cells. This may be the case in rheumatoid arthritis, where cytomegalovirus-specific KIR2DS2(+) T cells might cause vasculitis. Thus, the rapid evolution of activating KIR may have allowed for efficient NK-cell control of viruses, but may also have increased the risk that slowly evolving T-cell responses to persistent pathogens derail into autoimmunity.
© 2010 The Authors. Immunology © 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20722764      PMCID: PMC2996550          DOI: 10.1111/j.1365-2567.2010.03337.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  86 in total

1.  The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells.

Authors:  J R Ortaldo; R Winkler-Pickett; A T Mason; L H Mason
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

2.  Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3.

Authors:  Hans-Ingo Trompeter; Natalia Gómez-Lozano; Simeon Santourlidis; Britta Eisermann; Peter Wernet; Carlos Vilches; Markus Uhrberg
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

3.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

Authors:  S Bauer; V Groh; J Wu; A Steinle; J H Phillips; L L Lanier; T Spies
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

4.  Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis.

Authors:  M Hooper; E G Kallas; D Coffin; D Campbell; T G Evans; R J Looney
Journal:  J Rheumatol       Date:  1999-07       Impact factor: 4.666

5.  Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells.

Authors:  Nicolas Anfossi; Jean-Marc Doisne; Marie-Alix Peyrat; Sophie Ugolini; Olivia Bonnaud; David Bossy; Vincent Pitard; Pierre Merville; Jean-François Moreau; Jean-François Delfraissy; Julie Dechanet-Merville; Marc Bonneville; Alain Venet; Eric Vivier
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

6.  Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors.

Authors:  Jeroen van Bergen; Allan Thompson; Arno van der Slik; Tom H M Ottenhoff; Jacobijn Gussekloo; Frits Koning
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

7.  Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.

Authors:  M Valés-Gómez; H T Reyburn; R A Erskine; J Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Authors:  Mónica Gumá; Ana Angulo; Carlos Vilches; Natalia Gómez-Lozano; Núria Malats; Miguel López-Botet
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

9.  Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.

Authors:  C C Winter; J E Gumperz; P Parham; E O Long; N Wagtmann
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

10.  Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues.

Authors:  Laurent Abi-Rached; Peter Parham
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307

View more
  11 in total

1.  Polymorphism of killer cell immunoglobulin-like receptors (KIR) and their HLA ligands in Graves' disease.

Authors:  Romina Dastmalchi; Ali Farazmand; Sina Noshad; Mohamad Mozafari; Mahdi Mahmoudi; Alireza Esteghamati; Aliakbar Amirzargar
Journal:  Mol Biol Rep       Date:  2014-05-23       Impact factor: 2.316

2.  CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells.

Authors:  Niklas K Björkström; Vivien Béziat; Frank Cichocki; Lisa L Liu; Jeffrey Levine; Stella Larsson; Richard A Koup; Stephen K Anderson; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2012-09-11       Impact factor: 22.113

3.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

4.  Multiplex and genome-wide analyses reveal distinctive properties of KIR+ and CD56+ T cells in human blood.

Authors:  Wing Keung Chan; Piya Rujkijyanont; Geoffrey Neale; Jie Yang; Rafijul Bari; Neha Das Gupta; Martha Holladay; Barbara Rooney; Wing Leung
Journal:  J Immunol       Date:  2013-07-15       Impact factor: 5.422

Review 5.  Triggering receptor expressed on myeloid cells and 5'adenosine monophosphate-activated protein kinase in the inflammatory response: a potential therapeutic target.

Authors:  Finosh G Thankam; Matthew F Dilisio; Kaitlin A Dougherty; Nicholas E Dietz; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-06-13       Impact factor: 4.473

6.  NK-like T cells and plasma cytokines, but not anti-viral serology, define immune fingerprints of resilience and mild disability in exceptional aging.

Authors:  Abbe N Vallejo; David L Hamel; Robert G Mueller; Diane G Ives; Joshua J Michel; Robert M Boudreau; Anne B Newman
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

7.  Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms.

Authors:  Piotr Kuśnierczyk
Journal:  Front Immunol       Date:  2013-01-29       Impact factor: 7.561

8.  Expression patterns of killer cell immunoglobulin-like receptors (KIR) of NK-cell and T-cell subsets in Old World monkeys.

Authors:  Meike Hermes; Christina Albrecht; Annette Schrod; Markus Brameier; Lutz Walter
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

9.  Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3.

Authors:  Achim K Moesta; Peter Parham
Journal:  Front Immunol       Date:  2012-11-22       Impact factor: 7.561

Review 10.  HLA-C and HIV-1: friends or foes?

Authors:  Donato Zipeto; Alberto Beretta
Journal:  Retrovirology       Date:  2012-05-09       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.